Healthy Skepticism Library item: 4247
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: news
MaLAM Letter follow up—Upjohn announce worldwide withdrawal of Kaomycin
MaLAM Newsletter 1991 Jan
Abstract:
In response to MaLAM’s letter Upjohn has announced that it will phase out marketing of its antidiarrheal product Kaomycin.
Keywords:
*news story/developing countries/diarrhea/Upjohn/Kaomycin/company responses/MaLAM/Medical Lobby for Appropriate Marketing/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/PROMOTION IN SPECIFIC THERAPEUTIC AREAS: DIARRHEA/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES